吉利德科学更新ASCENT-07三期研究进展

投资观察
Nov 20, 2025

11月7日 - 吉利德科学公司发布了其ASCENT-07三期研究的更新:该研究未能达到无病进展生存期的主要终点;安全性资料与之前对Trodelvy乳腺癌的研究一致,且在该患者群体中未发现新的安全性信号。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10